Medicare Compliance & Reimbursement

Oncology:

Drug Admin Codes Hit With Thousands Of Edits

Prepare to justify using E/M codes with hydration or chemotherapy.

The new drug administration codes that Medicare introduced for 2005 may help physicians obtain a fair payment for their work in administering chemotherapy and other tough medications to patients. But good luck billing them alongside other procedures unless you can justify using a modifier.

For example, G0345 (Hydration therapy, first hour) and G0347 (Therapeutic/non-chemotherapy, first drug, first hour) will each become components of a shocking 5,687 codes. You'll be able to override all those edits with a modifier, except for ones bundling the two "G" codes with stereotactic lesion treatment code 77432 and lesion destruction code 67221. And 15 other codes, including Evaluation/Management CPT 99201 - CPT 99215 , will be components of G0345 and G0347. Of those, only 99211 will be immune to modifiers.

Also, G0351 (Intramuscular/subcutaneous injection) will become a component of 560 codes, including 161 surgery codes, 101 radiology codes and 33 medicine codes. 90788 (Intramuscular injection of an antibiotic) will become a component of G0351. Likewise, G0353 (IV push technique, non-chemotherapy) will become a component of a startling 705 codes, including many from the surgery, radiology and medicine areas. You'll be able to use a modifier to override these edits.

The new codes for chemotherapy administration (G0355-G0357) will become the comprehensive codes for 14 component codes each, including a number of E/M codes (99201-99215) and pump refilling/maintenance codes 96520-96530. A similar roster of codes will become components of chemotherapy infusion codes G0359 and G0361. You'll be able to use a modifier to override those edits as well.
 
Also, catheter maintenance (port flush) code G0363 will become a component of 10 codes, including most of the other new "G" codes, plus chemotherapy administration codes 96405-96406 and 96420-96425. You won't be able to use a modifier to override the edits involving G0363.
 
It makes sense that you can't override edits governing 99211, because the Centers for Medicare & Medicaid Services will only pay for "significant, separately identifiable" physician visits with chemotherapy or infusion, says Cindy Parman with Coding Strategies in Atlanta. Bundling the injection/infusion codes with surgery and radiology codes also makes sense because the administration of contrast or other agents isn't separately payable, Parman notes.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Medicare Compliance & Reimbursement

View All